Bristol Myers Squibb stands tall as the undisputed leader in the molecular glue arena, shaping the future of targeted therapies. With its groundbreaking advancements, the company has redefined the potential of molecular glues in oncology, offering innovative solutions that precisely degrade harmful proteins. Bristol Myers Squibb’s relentless commitment to scientific excellence and transformative research positions it at the forefront of this rapidly evolving field, paving the way for novel, life-changing treatments that address some of the most complex diseases.
Bristol Myers Squibb — Dominating the Molecular Glue Sector
Bristol Myers Squibb headquartered in New...
